Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study

Gastroenterology. 2020 Sep;159(3):1129-1131.e3. doi: 10.1053/j.gastro.2020.05.053. Epub 2020 May 22.
No abstract available

Keywords: Coronavirus 2019; Famotidine; Histamine-2 Receptor Antagonists; SARS-CoV-2.

MeSH terms

  • Adult
  • Aged
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / mortality
  • Coronavirus Infections / virology
  • Famotidine / therapeutic use*
  • Female
  • Histamine H2 Antagonists / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / mortality
  • Pneumonia, Viral / virology
  • Propensity Score
  • Retrospective Studies
  • SARS-CoV-2
  • Treatment Outcome

Substances

  • Histamine H2 Antagonists
  • Famotidine

Supplementary concepts

  • COVID-19 drug treatment